vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and NL INDUSTRIES INC (NL). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $37.7M, roughly 1.3× NL INDUSTRIES INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -82.2%, a 77.4% gap on every dollar of revenue. On growth, NL INDUSTRIES INC posted the faster year-over-year revenue change (-1.9% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-4.7M). Over the past eight quarters, NL INDUSTRIES INC's revenue compounded faster (-0.4% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

NL Industries, formerly known as the National Lead Company, is a lead smelting company currently based in Houston, Texas. National Lead was one of the 12 original stocks included in the Dow Jones Industrial Average at the time of its creation on May 26, 1896.

IRWD vs NL — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.3× larger
IRWD
$47.7M
$37.7M
NL
Growing faster (revenue YoY)
NL
NL
+45.4% gap
NL
-1.9%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
77.4% more per $
IRWD
-4.8%
-82.2%
NL
More free cash flow
IRWD
IRWD
$79.3M more FCF
IRWD
$74.6M
$-4.7M
NL
Faster 2-yr revenue CAGR
NL
NL
Annualised
NL
-0.4%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
NL
NL
Revenue
$47.7M
$37.7M
Net Profit
$-2.3M
$-31.0M
Gross Margin
32.1%
Operating Margin
14.3%
7.6%
Net Margin
-4.8%
-82.2%
Revenue YoY
-47.3%
-1.9%
Net Profit YoY
-200.9%
-287.2%
EPS (diluted)
$0.01
$-0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
NL
NL
Q4 25
$47.7M
$37.7M
Q3 25
$122.1M
$40.0M
Q2 25
$85.2M
$40.4M
Q1 25
$41.1M
$40.3M
Q4 24
$90.5M
$38.4M
Q3 24
$91.6M
$33.7M
Q2 24
$94.4M
$35.9M
Q1 24
$74.9M
$38.0M
Net Profit
IRWD
IRWD
NL
NL
Q4 25
$-2.3M
$-31.0M
Q3 25
$40.1M
$-7.9M
Q2 25
$23.6M
$355.0K
Q1 25
$-37.4M
$667.0K
Q4 24
$2.3M
$16.5M
Q3 24
$3.6M
$36.0M
Q2 24
$-860.0K
$7.8M
Q1 24
$-4.2M
$6.8M
Gross Margin
IRWD
IRWD
NL
NL
Q4 25
32.1%
Q3 25
27.6%
Q2 25
31.9%
Q1 25
30.2%
Q4 24
28.8%
Q3 24
28.1%
Q2 24
31.1%
Q1 24
25.5%
Operating Margin
IRWD
IRWD
NL
NL
Q4 25
14.3%
7.6%
Q3 25
61.8%
4.6%
Q2 25
53.2%
6.9%
Q1 25
-70.7%
7.8%
Q4 24
34.8%
87.7%
Q3 24
28.0%
6.0%
Q2 24
26.5%
2.2%
Q1 24
14.7%
3.6%
Net Margin
IRWD
IRWD
NL
NL
Q4 25
-4.8%
-82.2%
Q3 25
32.8%
-19.7%
Q2 25
27.7%
0.9%
Q1 25
-90.9%
1.7%
Q4 24
2.5%
43.1%
Q3 24
4.0%
107.0%
Q2 24
-0.9%
21.8%
Q1 24
-5.6%
18.0%
EPS (diluted)
IRWD
IRWD
NL
NL
Q4 25
$0.01
$-0.63
Q3 25
$0.23
$-0.16
Q2 25
$0.14
$0.01
Q1 25
$-0.23
$0.01
Q4 24
$0.03
$0.34
Q3 24
$0.02
$0.74
Q2 24
$-0.01
$0.16
Q1 24
$-0.03
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
NL
NL
Cash + ST InvestmentsLiquidity on hand
$215.5M
$110.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$358.8M
Total Assets
$396.9M
$464.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
NL
NL
Q4 25
$215.5M
$110.6M
Q3 25
$140.4M
$101.9M
Q2 25
$92.9M
$111.5M
Q1 25
$108.5M
$110.0M
Q4 24
$88.6M
$163.2M
Q3 24
$88.2M
$146.0M
Q2 24
$105.5M
$179.4M
Q1 24
$121.5M
$167.9M
Total Debt
IRWD
IRWD
NL
NL
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
IRWD
IRWD
NL
NL
Q4 25
$-261.8M
$358.8M
Q3 25
$-264.2M
$375.4M
Q2 25
$-308.2M
$397.6M
Q1 25
$-334.1M
$397.6M
Q4 24
$-301.3M
$396.9M
Q3 24
$-311.3M
$386.0M
Q2 24
$-321.7M
$373.1M
Q1 24
$-330.5M
$368.1M
Total Assets
IRWD
IRWD
NL
NL
Q4 25
$396.9M
$464.2M
Q3 25
$396.1M
$500.2M
Q2 25
$342.9M
$523.7M
Q1 25
$327.2M
$520.0M
Q4 24
$350.9M
$578.3M
Q3 24
$389.5M
$585.6M
Q2 24
$395.6M
$580.0M
Q1 24
$438.8M
$568.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
NL
NL
Operating Cash FlowLast quarter
$74.6M
$-4.2M
Free Cash FlowOCF − Capex
$74.6M
$-4.7M
FCF MarginFCF / Revenue
156.3%
-12.6%
Capex IntensityCapex / Revenue
0.0%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$-40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
NL
NL
Q4 25
$74.6M
$-4.2M
Q3 25
$47.6M
$7.9M
Q2 25
$-15.1M
$7.3M
Q1 25
$20.0M
$-47.5M
Q4 24
$15.2M
$9.0M
Q3 24
$9.9M
$-5.7M
Q2 24
$33.5M
$15.5M
Q1 24
$45.0M
$6.7M
Free Cash Flow
IRWD
IRWD
NL
NL
Q4 25
$74.6M
$-4.7M
Q3 25
$47.6M
$7.0M
Q2 25
$-15.1M
$5.9M
Q1 25
$19.9M
$-48.3M
Q4 24
$8.7M
Q3 24
$9.9M
$-6.1M
Q2 24
$33.4M
$15.1M
Q1 24
$44.9M
$6.4M
FCF Margin
IRWD
IRWD
NL
NL
Q4 25
156.3%
-12.6%
Q3 25
39.0%
17.4%
Q2 25
-17.7%
14.7%
Q1 25
48.4%
-119.9%
Q4 24
22.8%
Q3 24
10.8%
-18.3%
Q2 24
35.4%
42.1%
Q1 24
60.0%
17.0%
Capex Intensity
IRWD
IRWD
NL
NL
Q4 25
0.0%
1.6%
Q3 25
0.0%
2.5%
Q2 25
0.0%
3.3%
Q1 25
0.1%
2.0%
Q4 24
0.0%
0.6%
Q3 24
0.0%
1.4%
Q2 24
0.1%
1.2%
Q1 24
0.1%
0.8%
Cash Conversion
IRWD
IRWD
NL
NL
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
20.53×
Q1 25
-71.18×
Q4 24
6.74×
0.54×
Q3 24
2.71×
-0.16×
Q2 24
1.98×
Q1 24
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

NL
NL

Security Products$29.5M78%
Marine Components$8.2M22%

Related Comparisons